Effectiveness of a culturally adapted biopsychosocial intervention (POHON SIHAT) in improving self-efficacy in patients with diabetes attending primary healthcare clinics in Putrajaya, Malaysia: study protocol of a randomised controlled trial.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

Original Publication: [London] : BMJ Publishing Group Ltd, 2011-

Culturally Competent Care* ; Diabetes Mellitus, Type 2*/psychology ; Diabetes Mellitus, Type 2*/therapy ; Self Efficacy*; Humans ; Malaysia ; Patient-Centered Care ; Primary Health Care ; Quality of Life ; Randomized Controlled Trials as Topic

Introduction: People with diabetes are often associated with multifaceted factors and comorbidities. Diabetes management frameworks need to integrate a biopsychosocial, patient-centred approach. Despite increasing efforts in promotion and diabetes education, interventions integrating both physical and mental health components are still lacking in Malaysia. The Optimal Health Programme (OHP) offers an innovative biopsychosocial framework to promote overall well-being and self-efficacy, going beyond education alone and has been identified as relevant within the primary care system. Following a comprehensive cultural adaptation process, Malaysia's first OHP was developed under the name 'Pohon Sihat' (OHP). The study aims to evaluate the effectiveness of the mental health-based self-management and wellness programme in improving self-efficacy and well-being in primary care patients with diabetes mellitus.
Methods and Analysis: This biopsychosocial intervention randomised controlled trial will engage patients (n=156) diagnosed with type 2 diabetes mellitus (T2DM) from four primary healthcare clinics in Putrajaya. Participants will be randomised to either OHP plus treatment as usual. The 2-hour weekly sessions over five consecutive weeks, and 2-hour booster session post 3 months will be facilitated by trained mental health practitioners and diabetes educators. Primary outcomes will include self-efficacy measures, while secondary outcomes will include well-being, anxiety, depression, self-care behaviours and haemoglobin A1c glucose test. Outcome measures will be assessed at baseline, immediately postintervention, as well as at 3 months and 6 months postintervention. Where appropriate, intention-to-treat analyses will be performed.
Ethics and Dissemination: This study has ethics approval from the Medical Research and Ethics Committee, Ministry of Health Malaysia (NMRR-17-3426-38212). Study findings will be shared with the Ministry of Health Malaysia and participating healthcare clinics. Outcomes will also be shared through publication, conference presentations and publication in a peer-reviewed journal.
Trial Registration Number: NCT03601884.
Competing Interests: Competing interests: DJC has received grant monies for research from Eli Lilly, Janssen Cilag, Roche, Allergen, Bristol-Myers Squibb, Pfizer, Lundbeck, Astra Zeneca, Hospira; Travel Support and Honoraria for Talks and Consultancy from Eli Lilly, Bristol-Myers Squibb, Astra Zeneca, Lundbeck, Janssen Cilag, Pfizer, Organon, Sanofi-Aventis, Wyeth, Hospira, Servier; and is a current Advisory Board Member for Lu AA21004: Lundbeck; Varenicline: Pfizer; Asenapine: Lundbeck; Bitopertin: Roche Aripiprazole LAI: Lundbeck; Lisdexamfetamine: Shire; Lurasidone: Servier. He has no stocks or shares in any pharmaceutical company.
(© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Med J Malaysia. 2012 Jun;67(3):309-15. (PMID: 23082424)
Jpn J Nurs Sci. 2009 Jun;6(1):51-63. (PMID: 19566639)
BMC Fam Pract. 2018 Mar 9;19(1):39. (PMID: 29523075)
Diabet Med. 2008 Jun;25(6):722-31. (PMID: 18435777)
Health Aff (Millwood). 2015 Sep;34(9):1498-505. (PMID: 26355051)
Nurs Health Sci. 2011 Sep;13(3):335-43. (PMID: 21812879)
J Prim Health Care. 2012 Mar 01;4(1):5-11, A1. (PMID: 22377544)
PLoS One. 2017 Mar 31;12(3):e0175096. (PMID: 28362861)
Diabet Med. 2013 Jul;30(7):767-77. (PMID: 23711019)
Br J Psychiatry. 2010 May;196(5):383-8. (PMID: 20435965)
Curr Diabetes Rev. 2016;12(3):240-51. (PMID: 26073610)
J Adv Nurs. 2017 May;73(5):1137-1146. (PMID: 27862194)
Psychol Health. 2015;30(2):153-64. (PMID: 25104430)
Clin Diabetes. 2015 Apr;33(2):97-111. (PMID: 25897193)
Patient Educ Couns. 2016 Feb;99(2):287-94. (PMID: 26341940)
Health Educ Res. 2011 Oct;26(5):896-907. (PMID: 21715653)
Ann Glob Health. 2015 Nov-Dec;81(6):851-62. (PMID: 27108152)
Diabetes Care. 2000 Jul;23(7):943-50. (PMID: 10895844)
Nurs Health Sci. 2012 Mar;14(1):38-45. (PMID: 22288688)
BMC Fam Pract. 2013 May 24;14:66. (PMID: 23705978)
Australas Psychiatry. 2019 Jun;27(3):262-266. (PMID: 30931582)
PLoS Med. 2013;10(5):e1001448. (PMID: 23737736)
Diabetes Care. 2003 May;26(5):1641-2. (PMID: 12716841)
Psychol Med. 2004 Aug;34(6):983-90. (PMID: 15554569)
J Thorac Dis. 2009 Dec;1(1):51-4. (PMID: 22263004)
Diabetes Res Clin Pract. 2017 Sep;131:179-186. (PMID: 28756132)
Diabetes Care. 2016 Dec;39(12):2126-2140. (PMID: 27879358)
Trials. 2016 Sep 09;17(1):445. (PMID: 27612634)
Diabetes Care. 2000 Jun;23(6):739-43. (PMID: 10840988)
BMJ Open. 2014 Apr 23;4(4):e004794. (PMID: 24760351)
J Adv Nurs. 1999 Aug;30(2):352-9. (PMID: 10457237)
Trials. 2016 Sep 09;17(1):444. (PMID: 27612943)
Aust Health Rev. 2012 Feb;36(1):1-7. (PMID: 22513012)
J Educ Health Promot. 2013 Jul 31;2:36. (PMID: 24083286)

Keywords: PRIMARY CARE; biopsychosocial; diabetes; self-efficacy; self-management

ClinicalTrials.gov NCT03601884

Date Created: 20200219 Date Completed: 20210408 Latest Revision: 20210408

20221213

PMC7044963

10.1136/bmjopen-2019-033920

32066607